Skip to content
Open access · CC-BY via OpenAlex

UA-30 ameliorates motor deficits through RalA-mediated mitophagy in ALS mice

Bingge Zhang, Ye He, Ting Su, Xiaomei Li, Xiufen Zhang, Ruijuan Liu, Xiao Han, Ruiming Zhang, Chao Yang, Xinlei Liu, Qinghua Hou, Zaijun Zhang, Xie Yongmei, Gongping Liu, Xifei Yang

Journal of Clinical Investigation · 2026

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive motor neuron loss, skeletal muscle atrophy, paralysis, and eventually death. Mitochondrial dysfunction(definition) plays a pivotal role in ALS pathogenesis, although the precise pathogenic mechanisms remain elusive, and effective therapeutic strategies are extremely limited. In this study, we developed a small-molecule inhibitor, UA-30, which directly targets RalA, and explored its potential for the treatment of ALS. We found that when administered via oral gavage for 6 weeks following the onset of motor deficit, UA-30 extended lifespan and improved motor function of SOD1G93A mice, a model of ALS. UA-30 ameliorated motor neuron loss, neuroinflammation, fibrosis, and mitochondrial dysfunction, as evidenced by energy recovery, decreased oxidative stress, and enhanced mitophagy. Mechanistically, UA-30 inhibited RalA activity and thereby modulated ERK/FOXO3a signaling, which inhibited FOXO3a degradation via the ubiquitin-proteasome pathway; enhanced FOXO3a stability; and upregulated the expression of mitophagy-related genes in this ALS mouse model. The beneficial effects of UA-30 in ALS were abolished by overexpression of the constitutively active form of RalA (RalAG23V) or Mdivi-1 treatment. These findings support RalA inhibition as a therapeutic strategy for enhancing mitophagy and mitigating ALS-like pathology and support UA-30 as an orally active candidate for further preclinical development.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1172/jci202787
Canonical
link ↗
Fetched
2026-11-12 MST

Cite this

APA
Zhang, B., He, Y., Su, T., Li, X., Zhang, X., Liu, R., Han, X., Zhang, R., Yang, C., Liu, X., Hou, Q., Zhang, Z., Yongmei, X., Liu, G., &amp; Yang, X. (2026). UA-30 ameliorates motor deficits through RalA-mediated mitophagy in ALS mice. <em>Journal of Clinical Investigation</em>. https://doi.org/10.1172/jci202787
Vancouver
Zhang B, He Y, Su T, Li X, Zhang X, Liu R, et al. UA-30 ameliorates motor deficits through RalA-mediated mitophagy in ALS mice. Journal of Clinical Investigation. 2026. doi:10.1172/jci202787.
BibTeX
@article{bingge2026UAamel, title = {UA-30 ameliorates motor deficits through RalA-mediated mitophagy in ALS mice}, author = {Bingge Zhang and Ye He and Ting Su and Xiaomei Li and Xiufen Zhang and Ruijuan Liu and Xiao Han and Ruiming Zhang and Chao Yang and Xinlei Liu and Qinghua Hou and Zaijun Zhang and Xie Yongmei and Gongping Liu and Xifei Yang}, journal = {Journal of Clinical Investigation}, year = {2026}, doi = {10.1172/jci202787}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings